ABVX vs. AZN

Last updated Apr 1, 2026

Compare and contrast key facts about Abivax SA American Depositary Shares (ABVX) and AstraZeneca PLC (AZN).

Performance

ABVX vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Abivax SA American Depositary Shares (ABVX) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

ABVX vs. AZN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
ABVX Abivax SA American Depositary Shares	-17.43%	1,742.28%	-31.59%	28.92%
AZN AstraZeneca PLC	9.51%	43.30%	-0.62%	5.51%

Fundamentals

Market Cap ABVX : $7.74B AZN : $308.06B
EPS ABVX : -$6.89 AZN : $6.55
PS Ratio ABVX : 685.81 AZN : 5.24
PB Ratio ABVX : 17.01 AZN : 6.33
Total Revenue (TTM) ABVX : $10.79M AZN : $58.74B
Gross Profit (TTM) ABVX : $9.76M AZN : $48.11B
EBITDA (TTM) ABVX : -$411.59M AZN : $19.83B

Returns By Period

In the year-to-date period, ABVX achieves a -17.43% return, which is significantly lower than AZN's 9.51% return.

ABVX

• 1D: 9.70%
• 1M: -8.19%
• YTD: -17.43%
• 6M: 31.15%
• 1Y: 1,681.60%
• 3Y*: —
• 5Y*: —
• 10Y*: —

AZN

• 1D: 1.72%
• 1M: -5.39%
• YTD: 9.51%
• 6M: 31.22%
• 1Y: 37.92%
• 3Y*: 15.06%
• 5Y*: 17.44%
• 10Y*: 16.71%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ABVX vs. AZN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABVX

ABVX Risk / Return Rank: 99
ABVX Sharpe Ratio Rank: 96
ABVX Sortino Ratio Rank: 100
ABVX Omega Ratio Rank: 100
ABVX Calmar Ratio Rank: 100
ABVX Martin Ratio Rank: 100

AZN

AZN Risk / Return Rank: 83
AZN Sharpe Ratio Rank: 83
AZN Sortino Ratio Rank: 81
AZN Omega Ratio Rank: 78
AZN Calmar Ratio Rank: 87
AZN Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABVX vs. AZN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Abivax SA American Depositary Shares (ABVX) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ABVX	AZN	Difference
Sharpe ratio Return per unit of total volatility	2.89	1.40	+1.49
Sortino ratio Return per unit of downside risk	19.60	2.07	+17.53
Omega ratio Gain probability vs. loss probability	3.34	1.27	+2.07
Calmar ratio Return relative to maximum drawdown	54.12	3.20	+50.92
Martin ratio Return relative to average drawdown	134.94	8.03	+126.91
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ABVX vs. AZN - Sharpe Ratio Comparison

The current ABVX Sharpe Ratio is 2.89, which is higher than the AZN Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of ABVX and AZN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ABVX	AZN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.89	1.40	+1.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.74	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.67	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.50	0.51	0.00

Correlation

The correlation between ABVX and AZN is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ABVX vs. AZN - Dividend Comparison

ABVX has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 2.70%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABVX Abivax SA American Depositary Shares	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
AZN AstraZeneca PLC	2.70%	1.70%	2.27%	2.15%	2.12%	2.35%	2.80%	2.81%	3.69%	3.95%	5.01%	4.06%

Drawdowns

ABVX vs. AZN - Drawdown Comparison

The maximum ABVX drawdown since its inception was -67.46%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for ABVX and AZN.

Drawdown Indicators

	ABVX	AZN	Difference
Max Drawdown Largest peak-to-trough decline	-67.46%	-48.94%	-18.52%
Max Drawdown (1Y) Largest decline over 1 year	-30.15%	-12.24%	-17.91%
Max Drawdown (5Y) Largest decline over 5 years	—	-27.87%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-27.87%	—
Current Drawdown Current decline from peak	-23.37%	-5.39%	-17.98%
Average Drawdown Average peak-to-trough decline	-23.96%	-11.39%	-12.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.09%	4.88%	+7.21%

Volatility

ABVX vs. AZN - Volatility Comparison

Abivax SA American Depositary Shares (ABVX) has a higher volatility of 18.55% compared to AstraZeneca PLC (AZN) at 6.95%. This indicates that ABVX's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABVX	AZN	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.55%	6.95%	+11.60%
Volatility (6M) Calculated over the trailing 6-month period	43.61%	19.14%	+24.47%
Volatility (1Y) Calculated over the trailing 1-year period	589.00%	27.28%	+561.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	380.44%	23.83%	+356.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	380.44%	24.90%	+355.54%

Financials